These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9587111)

  • 1. Population screening for colorectal carcinoma with fecal-occult blood testing: are we sufficiently informed?
    Agrez MV; Coory M; Cockburn J
    Cancer; 1998 May; 82(10):1803-7. PubMed ID: 9587111
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal occult blood test for colorectal cancer screening.
    Strul H; Arber N
    Ann Oncol; 2002 Jan; 13(1):51-6. PubMed ID: 11863111
    [No Abstract]   [Full Text] [Related]  

  • 3. Fecal occult blood testing for colorectal cancer: a perspective.
    Barry MJ
    Ann Oncol; 2002 Jan; 13(1):61-4. PubMed ID: 11863113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood testing for colorectal cancer. Can we afford not to do this?
    Bond JH
    Gastroenterol Clin North Am; 1997 Mar; 26(1):57-70. PubMed ID: 9119440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood testing: best option for colorectal cancer screening in Asia?
    Sharma SP
    J Natl Cancer Inst; 2008 Aug; 100(15):1056-7. PubMed ID: 18664644
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 11. Fecal occult blood testing for colorectal cancer. Can we afford to do this?
    Ahlquist DA
    Gastroenterol Clin North Am; 1997 Mar; 26(1):41-55. PubMed ID: 9119439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should organised faecal occult blood test screening be established?
    Autier P
    Ann Oncol; 2002 Jan; 13(1):57-60. PubMed ID: 11863112
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should there be mass screening using faecal occult blood tests for colorectal cancer?
    Faivre J; Tazi MA; Autier P; Bleiberg H
    Eur J Cancer; 1998 May; 34(6):773-80. PubMed ID: 9797686
    [No Abstract]   [Full Text] [Related]  

  • 15. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
    Stern C
    Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening and surveillance for colorectal carcinoma.
    Markowitz AJ; Winawer SJ
    Hematol Oncol Clin North Am; 1997 Aug; 11(4):579-608. PubMed ID: 9257147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal occult blood testing (FOBT) as screening for colorectal cancer: the current controversy.
    Boyle P
    Ann Oncol; 2002 Jan; 13(1):16-8. PubMed ID: 11863098
    [No Abstract]   [Full Text] [Related]  

  • 19. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 20. In the clinic. Screening for colorectal cancer.
    Weinberg DS; Schoen RE
    Ann Intern Med; 2014 May; 160(9):. PubMed ID: 24798544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.